Article

Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant.

Program in Reproductive and Adult Endocrinology, NICHD, National Institutes of Health, Bethesda, Maryland 20892, USA.
Fertility and sterility (impact factor: 3.97). 11/2008; 91(4 Suppl):1529-32. DOI:10.1016/j.fertnstert.2008.08.123 pp.1529-32
Source: PubMed

ABSTRACT In this small pilot study, anti-Müllerian hormone (AMH) levels in women undergoing chemotherapy and hematopoietic stem cell transplantation facilitated earlier identification of impaired ovarian reserve compared with FSH and the resumption of menses. Larger studies are needed to accurately assess the clinical significance of AMH levels in the prediction of long-term reproductive outcomes in reproductive-age transplant patients with our current conditioning regimen.

0 0
 · 
0 Bookmarks
 · 
23 Views
  • Article: Hypertension, antihypertensive therapy, and erectile dysfunction.
    Athanasios G Papatsoris, Panagiotis G Korantzopoulos
    [show abstract] [hide abstract]
    ABSTRACT: Erectile dysfunction represents a common problem in the male hypertensive population. Both erectile dysfunction and hypertension share common pathophysiologic pathways such as atherosclerosis and endothelial dysfunction. Furthermore, traditional cardiovascular risk factors affect both conditions. Notably, several antihypertensive medications seem to adversely affect erectile function whereas others may exert neutral or even favorable effects. Thus, the regular and meticulous clinical evaluation of hypertensive patients, as well as individualization of anti-hypertensive therapy, are important steps in the effective management of such patients. In addition, the administration of phosphodiesterase-5 inhibitors or apomorphine has excellent efficacy and safety profile in hypertensive patients irrespective of taking or not taking antihypertensive medications.
    Angiology 57(1):47-52. · 1.51 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

cell transplantation facilitated
 
clinical significance
 
current conditioning regimen
 
Larger studies
 
long-term reproductive outcomes
 
ovarian reserve
 
reproductive-age transplant patients
 
small pilot study
 
women undergoing chemotherapy
 

Hyacinth Browne